Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

3 Analysts Reiterate Buy Rating On Splunk

Published 11/30/2016, 03:14 PM
Updated 07/09/2023, 06:32 AM

Here are today’s top Wall Street analyst ratings where finbox.io’s unbiased fair value estimates support the recommendation.

Top Upgrades and Buy Ratings

  • Aegis initiated coverage on Globus Medical (NYSE:GMED) at Buy and set a $31 price target. Ten valuation models conclude an intrinsic value closer to $28 per share which still implies over 25% upside.

Globus Medical Fair Value

  • Wells Fargo reiterated Kroger (NYSE:KR) at Outperform and set a $37.50 target. Finbox.io’s fair value estimate is even higher at approximately $40 per share.

Kroger Fair Value

  • Jefferies Group, Wedbush and Pacific Crest all reiterated their Buy rating on Splunk (NASDAQ:SPLK). The company’s fundamentals support the ratings. Shares currently have 18% margin of safety.

Splunk Fair Value

Top Downgrades

  • Northcoast Research downgraded ABAXIS (NASDAQ:ABAX) from Buy to Neutral. Shares are currently trading at a large premium.

Abaxis Fair Value

  • US Capital Advisors downgraded South Jersey Industries (NYSE:SJI) from Buy to Hold. Nine free cash flow models imply the stock is 24% overvalued.

South Jersey Industries Fair Value

  • Berenberg Bank downgraded Freeport-McMoran (NYSE:FCX) from Hold to Sell along with a $10.90 price target. Fundamentals support the rating change.

Freeport-McMoRan Fair Value

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.